Mar­ket­ingRx roundup: Amer­i­cans still di­vid­ed over Covid boost­ers; Am­gen ramps up ac­tiv­i­ty on Threads

Covid vac­cine mak­ers Pfiz­er, Mod­er­na and No­vavax have all ramped up US mar­ket­ing and ad­ver­tis­ing ef­forts this fall, but some Amer­i­cans still aren’t con­vinced.

A new Ip­sos poll finds 43% of Amer­i­cans are like­ly to get a boost­er, but on­ly 30% are “very like­ly” to get a boost­er shot. Mean­while, a very sol­id 37% said they are “not at all like­ly” to get it. About 6% had al­ready re­ceived a Covid boost­er by the poll tak­en the first week of Oc­to­ber.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.